Senti Biosciences Holdings, Inc. (SNTI) Executive Compensation
Senti Biosciences Holdings, Inc. (SNTI) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SNTI
CIK: 1854270
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerLindsay Brusco
Audit LocationSan Francisco, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-15 | 2026-10-15 | 8-K | 0001628280-26-065992 | View SEC Doc Filr Page |
| DEFA14A | 2026-10-13 | — | DEFA14A | 0001628280-26-065686 | View SEC Doc Filr Page |
| 8-K | 2026-10-13 | 2026-10-08 | 8-K | 0001628280-26-065685 | View SEC Doc Filr Page |
| EFFECT | 2026-09-24 | — | EFFECT Filing | 9999999995-26-003050 | View SEC Doc Filr Page |
| DEFM14A | 2026-09-24 | — | DEFM14A | 0001140361-26-037574 | View SEC Doc Filr Page |
| 424B3 | 2026-09-24 | — | 424B3 | 0001193125-26-401118 | View SEC Doc Filr Page |
| 8-K | 2026-09-24 | 2026-09-23 | 8-K | 0001628280-26-063369 | View SEC Doc Filr Page |
| PRER14A | 2026-09-24 | — | PRER14A | 0001140361-26-037470 | View SEC Doc Filr Page |
| S-3/A | 2026-09-22 | — | S-3/A | 0001193125-26-397190 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-09-11 | — | SCHEDULE 13D/A Filing | 0000902664-26-003795 | View SEC Doc Filr Page |
| S-3/A | 2026-09-10 | — | S-3/A | 0001193125-26-388031 | View SEC Doc Filr Page |
| PRER14A | 2026-09-04 | — | PRER14A | 0001140361-26-035672 | View SEC Doc Filr Page |
| DEFA14A | 2026-09-04 | — | DEFA14A | 0001628280-26-060602 | View SEC Doc Filr Page |
| 8-K | 2026-09-04 | 2026-09-03 | 8-K | 0001628280-26-060600 | View SEC Doc Filr Page |
| DEFA14A | 2026-09-02 | — | DEFA14A | 0001628280-26-060129 | View SEC Doc Filr Page |
| 8-K | 2026-09-02 | 2026-08-27 | 8-K | 0001628280-26-060124 | View SEC Doc Filr Page |
| DEFA14A | 2026-08-20 | — | DEFA14A | 0001628280-26-058260 | View SEC Doc Filr Page |
| 8-K | 2026-08-20 | 2026-08-14 | 8-K | 0001628280-26-058258 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001628280-26-057110 | View SEC Doc Filr Page |
| ARS | 2026-07-21 | 2025-12-31 | ARS | 0001140361-26-029161 | View SEC Doc Filr Page |
| PREM14A | 2026-07-21 | 2026-08-18 | PREM14A | 0001140361-26-029160 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-16 | — | SCHEDULE 13D/A Filing | 0000902664-26-003126 | View SEC Doc Filr Page |
| S-3/A | 2026-07-16 | — | S-3/A | 0001193125-26-305347 | View SEC Doc Filr Page |
| DEFA14A | 2026-07-15 | — | DEFA14A | 0001628280-26-048249 | View SEC Doc Filr Page |
| 8-K | 2026-07-15 | 2026-07-14 | 8-K | 0001628280-26-048248 | View SEC Doc Filr Page |